News and Announcements
Omni Market Tide Funding Secures Additional Funding Support & Set To Raise $1.3m
- Published April 13, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
OMNI MARKET TIDE’S corporate objective is to be the leader in the Digital Engagement in Australia. It will achieve this by continuing its business to drive the development of OMT’s technology platform and migrate companies both listed and unlisted onto it, to enable the clients of OMT to engage digitally with their stakeholders in ways that have never been done before, while at the same time providing a very unique and valuable end user (being investors) experience.
KEY TAKEAWAYS:
OMT’s release of Its Audited Financial Report and Annual report on 3 April 2017, the Company is pleased to advise that is has now:
- Secured additional funding support of $150,000 from Mr Glenn Vassallo, the chairman of the Company; and
- Executed a conditional mandate to raise up to $1,300,000 In funding through equity as outlined in the going concern not on page 49 of the Audited Financial Report.
The sequence of the funding steps for the Company are as follows:
- Mr Glenn Vassallo has agreed to immediately loan the Company $150, 000 at no interest which will become a convertible note subject to shareholder approval and will convert at 2.5 cents per share post-consolidation basis. Shareholder approval will be sought at the forthcoming Annual General Meeting in late May 2017.
- The existing unsecured convertible note holders totalling $250, 000 will also convert at 2.5 cents per share on a post-consolidation basis. On a post consolidation basis (and subject to shareholder approval if it is required), a total of 16 million shares will be issued from converting the existing unsecured convertible notes and Mr Glenn Vassallo’s new convertible note; and
- A mandate to raise capital has been executed with Forrest Capital to raise $1,300,000 at 1.25 cents per share following a proposed 10:1 share consolidation. The Placement will be settled upon receiving shareholder approval at the forthcoming Annual General Meeting in late May 2017. Transaction costs for the placement are 6% of funds raised together with the grant of 35 million unlisted options at an exercise price of 2.5 cents expiring March 2021.
To request more information on Omni Market Tide, please click on the button below.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
